findmyKOL
Clinical trialNCT05698212RecruitingPhase 2Interventional

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

SponsorHera Biotech, Inc.Enrollment75DiagnosisEndometriosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Valley Ob-Gyn Clinic, Pc

    Saginaw, Michigan, United States

    Jacqueline A Robinsons, MD
    Not, yet, recruiting
  • Corpus Christi Women'S Center

    Corpus Christi, Texas, United States

    Charles R Kirkham, MD
    Recruiting
  • University of Texas Physician'S Women'S Center--Memorial City

    Houston, Texas, United States

    Sandry Hurtago, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Sept 2022
Primary completion
25 Mar 2023
Completion
10 Apr 2023
Last update posted
26 Jan 2023
Registered enrollment
75
Registry id
NCT05698212

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.